MGTA - Magenta Therapeutics GAAP EPS of -$0.29 beats by $0.06 August, 04 2022 09:06 AM Magenta Therapeutics Inc. Magenta Therapeutics press release ( NASDAQ: MGTA ): Q2 GAAP EPS of -$0.29 beats by $0.06 . Cash, cash equivalents and marketable securities as of June 30, 2022, were $139.4 million For further details see: Magenta Therapeutics GAAP EPS of -$0.29 beats by $0.06